New device aims to quiet an overactive bladder without drugs

NCT ID NCT07209397

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a device that uses radiofrequency energy inside the vagina to treat overactive bladder in women. It includes 202 women aged 22 to 80 who have had symptoms for at least 6 months. Half will get the real treatment and half a sham (fake) treatment to see if the device safely reduces urgent urine leaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC OVERACTIVE BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder Urinary Incontinence, Urge

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Specialty Research

    RECRUITING

    Boise, Idaho, 83702, United States

  • Atrium Health Wake Forest Female Pelvic Health Division

    RECRUITING

    Winston-Salem, North Carolina, 27103, United States

  • Bay State Clinical Trials

    RECRUITING

    Watertown, Massachusetts, 02472, United States

  • Cypress Medical Research Center

    RECRUITING

    Wichita, Kansas, 67226, United States

  • MedStar Health Research Institute

    NOT_YET_RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Stanford Medicine Department of Obstetrics & Gynecology

    NOT_YET_RECRUITING

    Palo Alto, California, 94304, United States

  • UNLV Kirk Kerkorian School of Medicine Department of Gynecologic Surgery & Obstetrics

    NOT_YET_RECRUITING

    Las Vegas, Nevada, 89154, United States

  • University of Chicago Medicine Urogynecology

    NOT_YET_RECRUITING

    Chicago, Illinois, 60062, United States

  • Urology Center, P.C.

    RECRUITING

    Omaha, Nebraska, 68114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.